A blood test result is a number. That number only becomes useful when you know what to do with it. Between the raw data of a biological panel and the quantity of a bioactive poured into a jar, there is a series of logical operations that, taken together, constitute what we call a precision formulation. This chain of reasoning is neither mysterious nor arbitrary. It is structured, documented, and entirely grounded in the scientific literature.
This article describes its main steps.
Step 1: Reading a biological data point, not just a figure
When a laboratory transmits a result, it comes with a reference range. That range is built on the statistical distribution of an apparently healthy general population. It is therefore, by definition, population-level. It says nothing about your individual biology.
The distinction between "normal" and "optimal" is one of the most important in precision nutrition.
Take ferritin, the marker of the body's iron stores. The laboratory reference range is often set between 12 and 150 µg/L for an adult woman. A result of 18 µg/L will be classified as "normal." Yet data from the literature indicates that ferritin below 30 µg/L is associated with persistent fatigue, even in the absence of anemia (PubMed). The relevant interpretation is not binary (within or outside the norm): it is positional, within a target zone defined by functional biology.
The first algorithmic operation therefore consists of positioning each value on a continuum, not classifying it as "normal" or "abnormal." The further a result sits from the target zone, the stronger the signal. This initial weighting conditions everything that follows.
Step 2: The dose-response curve, or why "more" is not always "better"
Once a need has been identified, the next question is: how much bioactive is needed to shift the biomarker toward its target zone? This is where the concept of a dose-response curve comes in. And that curve is not linear.
For iron, research shows that the body regulates intestinal absorption via hepcidin. This hormone, produced by the liver, acts as a gatekeeper: its concentration rises within hours of an iron dose, limiting subsequent uptake (PubMed). A standard daily dose can therefore paradoxically result in lower cumulative absorption than an alternate-day protocol. The Stoffel et al. trial published in The Lancet Haematology showed that cumulative fractional absorption was significantly higher with alternate-day supplementation (21.8%) compared to consecutive daily dosing (16.3%) (PubMed). Dose is therefore only part of the equation. The rhythm of intake is part of it too.
For omega-3 fatty acids, the dose-response varies substantially depending on baseline status. A randomized controlled trial by Flock et al. showed that body-weight-adjusted dose alone accounted for 70% of the differences in biological response between individuals (PubMed). Someone whose erythrocyte omega-3 index (the proportion of omega-3 in red blood cell membranes) is already near the target requires a far lower intake than someone whose starting status is low. Applying the same dose to both profiles will inevitably over-supplement one and under-supplement the other.
Cumulative fractional iron absorption ranges from 16 to 22% depending on the supplementation schedule. Alternate-day protocols outperform daily consecutive protocols in controlled studies.
Step 3: The interaction matrix
No nutrient acts alone in the body. This biochemical reality is often underestimated in generic formulations, yet it is central to a precision approach.
Iron and zinc share the same intestinal transporter. A high concentration of one compresses the absorption of the other. Calcium inhibits non-heme iron absorption. Vitamin C, in contrast, enhances it by converting ferric iron (Fe3+, poorly absorbable) to ferrous iron (Fe2+, the form the intestine absorbs most readily). These interactions are not incidental. Hallberg and Hulthén developed as early as 2000 a comprehensive algorithmic model to predict real iron absorption based on the simultaneous composition of the diet (PubMed). That model incorporates phytates (compounds found in grains and legumes that bind minerals), polyphenols, calcium, animal proteins, and ascorbic acid (vitamin C) as independent variables.
This type of interaction matrix represents an additional calculation layer in any rigorous formulation. The goal is not simply to choose the right bioactives. It is to ensure they do not work against each other in the intestinal tract, and that potential synergies are put to use.
Step 4: Inter-individual variability as an input variable
Precision nutrition research has shown, repeatedly, that the same intervention produces radically different biological outcomes depending on the individual. The Zeevi et al. study, published in Cell in 2015, remains a particularly compelling demonstration of this principle: faced with identical meals, glycemic responses varied to such a degree that what was nutritionally optimal for one participant could be harmful for another (PubMed). The algorithm developed by the researchers integrated blood data, gut microbiota composition, physical activity, and dietary habits to predict these individual responses with significant accuracy.
The same reasoning applies to micronutrient supplementation. A meta-analysis by Walker et al. covering over 1,400 individuals across 14 trials showed that baseline omega-3 index level, administered dose, and formulation type (capsule, liquid oil, emulsion) together explained the majority of differences in biological response between individuals (PubMed). There is no universal dose of EPA+DHA. There is a dose suited to a given biological profile, at a given point in time.
For vitamin D, the data are equally clear. Standard recommendations substantially underestimate individual requirements, in part because they ignore the influence of skin pigmentation, body mass index, and genetics on the synthesis and metabolism of 25(OH)D (the circulating form of vitamin D, the one measured in blood tests) (PubMed).
What the algorithm does not do
It is important to define what this approach is not. A formulation algorithm does not establish a diagnosis. It does not predict the trajectory of a health condition. It translates measurable biological data into personalized bioactive calibration, within the framework of current knowledge and validated nutritional claims.
The precision of the output depends directly on the quality of the input: recent biomarkers, obtained under standardized conditions, remain the necessary prerequisite for any genuinely individualized formulation. A blood panel from three years ago, in a radically different life context, is no longer a reliable reflection of your current biological profile.
This is why precision nutrition is not a one-time event, but an iterative process. The formulation adjusts because biology evolves. The most interesting question is not what your biology looks like today, but how closely the calibration tracks it over time.
Frequently asked questions
References
- Moretti D, Goede JS, Zeder C, et al. Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. Blood. 2015;126(17):1981-1989 (PubMed).
- Stoffel NU, Cercamondi CI, Brittenham G, et al. Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials. Lancet Haematol. 2017;4(11):e524-e533 (PubMed).
- Flock MR, Skulas-Ray AC, Harris WS, Etherton TD, Fleming JA, Kris-Etherton PM. Determinants of erythrocyte omega-3 fatty acid content in response to fish oil supplementation: a dose-response randomized controlled trial. J Am Heart Assoc. 2013;2(6):e000513 (PubMed).
- Hallberg L, Hulthén L. Prediction of dietary iron absorption: an algorithm for calculating absorption and bioavailability of dietary iron. Am J Clin Nutr. 2000;71(5):1147-1160 (PubMed).
- Zeevi D, Korem T, Zmora N, et al. Personalized Nutrition by Prediction of Glycemic Responses. Cell. 2015;163(5):1079-1094 (PubMed).
- Walker RE, Jackson KH, Tintle NL, et al. Predicting the effects of supplemental EPA and DHA on the omega-3 index. Am J Clin Nutr. 2019;110(4):1034-1040 (PubMed).
- Papadimitriou DT. The Big Vitamin D Mistake. J Prev Med Public Health. 2017;50(4):278-281 (PubMed).
